Literature DB >> 34041718

Knockdown of HCG18 Inhibits Cell Viability, Migration and Invasion in Pediatric Osteosarcoma by Targeting miR-188-5p/FOXC1 Axis.

Zhongquan Zhao1, Jiechao Chen2, Dezhi Xia3.   

Abstract

Understanding the underlying mechanisms of pediatric osteosarcoma (OS) migration and invasion is important for prognosis and treatment. We tried to measure the expression of long non-coding RNA HLA complex group 18 (HCG18) in OS and reveal its function in the malignant behaviors of OS cells. This study detected the expression of HCG18, miR-188-5p and forkhead box C1 (FOXC1) in OS tissues and cell lines by quantitative real-time PCR (qRT-PCR). The relevance between miR-188-5p and HCG18 or FOXC1 was affirmed by dual-luciferase reporter (DLR) assay. Cell viability was analyzed by MTT assay. Transwell assay was utilized to test cell invasion and migration. FOXC1 protein expression was detected by western blot. HCG18 expression was elevated in OS tissues, and enhanced HCG18 expression was related to metastasis. HCG18 silencing repressed the viability, migration and invasion of OS cells. Moreover, HCG18 interacted with miR-188-5p. MiR-188-5p up-regulation repressed cell viability, invasion and migration in OS cells. FOXC1, a known target of miR-188-5p, was negatively modulated by miR-188-5p. Furthermore, miR-188-5p inhibition or FOXC1 over-expression partially abolished the reduced of cell viability, invasion and migration mediated by HCG18 silencing in OS cell lines. This study revealed that HCG18 knockdown repressed the viability, invasion and migration of OS cells by targeting miR-188-5p and regulating FOXC1 expression. Thus, HCG18/ miR-188-5p/FOX may be a hopeful target for OS therapy.
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Forkhead box C1; HLA complex group 18; Invasion and migration; Osteosarcoma; miR-188-5p

Mesh:

Substances:

Year:  2021        PMID: 34041718     DOI: 10.1007/s12033-021-00343-6

Source DB:  PubMed          Journal:  Mol Biotechnol        ISSN: 1073-6085            Impact factor:   2.695


  32 in total

1.  LncRNA HIF2PUT inhibited osteosarcoma stem cells proliferation, migration and invasion by regulating HIF2 expression.

Authors:  Ding Zhao; Sisi Wang; Xu Chu; Dongfeng Han
Journal:  Artif Cells Nanomed Biotechnol       Date:  2019-12       Impact factor: 5.678

Review 2.  Osteosarcoma: ESMO clinical recommendations for diagnosis, treatment and follow-up.

Authors:  S Bielack; D Carrle; P G Casali
Journal:  Ann Oncol       Date:  2009-05       Impact factor: 32.976

3.  An immune-related lncRNA signature for patients with anaplastic gliomas.

Authors:  Wen Wang; Zheng Zhao; Fan Yang; Haoyuan Wang; Fan Wu; Tingyu Liang; Xiaoyan Yan; Jiye Li; Qing Lan; Jiangfei Wang; Jizong Zhao
Journal:  J Neurooncol       Date:  2017-11-23       Impact factor: 4.130

Review 4.  History, Discovery, and Classification of lncRNAs.

Authors:  Julien Jarroux; Antonin Morillon; Marina Pinskaya
Journal:  Adv Exp Med Biol       Date:  2017       Impact factor: 2.622

5.  NOTCH1 regulates the proliferation and migration of bladder cancer cells by cooperating with long non-coding RNA HCG18 and microRNA-34c-5p.

Authors:  Zhihui Xu; Banggao Huang; Qi Zhang; Xiang He; Haibin Wei; Dahong Zhang
Journal:  J Cell Biochem       Date:  2018-11-13       Impact factor: 4.429

6.  LncRNA SNHG4 promotes tumour growth by sponging miR-224-3p and predicts poor survival and recurrence in human osteosarcoma.

Authors:  Ruida Xu; Fan Feng; Xiaosheng Yu; Zude Liu; Lifeng Lao
Journal:  Cell Prolif       Date:  2018-08-28       Impact factor: 6.831

7.  HNF1A-Induced lncRNA HCG18 Facilitates Gastric Cancer Progression by Upregulating DNAJB12 via miR-152-3p.

Authors:  Pei Ma; Lianhai Li; Fu Liu; Qi Zhao
Journal:  Onco Targets Ther       Date:  2020-08-03       Impact factor: 4.147

Review 8.  Osteosarcoma: Current Treatment and a Collaborative Pathway to Success.

Authors:  Michael S Isakoff; Stefan S Bielack; Paul Meltzer; Richard Gorlick
Journal:  J Clin Oncol       Date:  2015-08-24       Impact factor: 44.544

Review 9.  LncRNAs Regulatory Networks in Cellular Senescence.

Authors:  Pavan Kumar Puvvula
Journal:  Int J Mol Sci       Date:  2019-05-28       Impact factor: 5.923

Review 10.  The efficacy and safety comparison of first-line chemotherapeutic agents (high-dose methotrexate, doxorubicin, cisplatin, and ifosfamide) for osteosarcoma: a network meta-analysis.

Authors:  Bin Zhang; Yan Zhang; Rongzhen Li; Jiazhen Li; Xinchang Lu; Yi Zhang
Journal:  J Orthop Surg Res       Date:  2020-02-13       Impact factor: 2.359

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.